This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Sorin Crm Sas. Active years: 2018-2021.
Company Filing History:
Years Active: 2018-2021
Title: The Innovations of Guillaume Chatalic
Introduction
Guillaume Chatalic is a notable inventor based in Clamart, France. He has made significant contributions to the field of medical technology, particularly in neurostimulation devices. With a total of 2 patents, his work focuses on improving the efficacy and functionality of medical devices.
Latest Patents
Chatalic's latest patents include an active implantable medical neurostimulation device with sectoral electrodes that are switchable according to various configurations. This innovative device features a generator of electric current pulses and a neurostimulation probe with multiple sectoral electrodes. These electrodes form stimulation poles for passing current between at least one anode and one cathode in predetermined configurations. The generator includes multiple current sources and sinks, allowing for dynamic switching to define various commutation combinations, thus providing a consistent average current for stimulation.
Another significant patent involves the use of an implantable cardiac pacing, defibrillation, and/or resynchronization generator as a vagus nerve stimulation (VNS) generator. In this design, a cardiac lead is replaced by a VNS lead, and the control circuit is configured to generate sequences of VNS neurostimulation bursts. This system dynamically adjusts the initial load voltage to maintain a constant target value for the electrical charge delivered to the nerve, enhancing the consistency of physiological effects despite variations in impedance.
Career Highlights
Chatalic works at Sorin CRM SAS, a company known for its advancements in cardiac and neurostimulation technologies. His role involves the development of innovative medical devices that aim to improve patient outcomes and enhance the quality of life for individuals with neurological conditions.
Collaborations
Throughout his career, Chatalic has collaborated with esteemed colleagues such as Jean-Claude Bierg and Thierry Legay. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Guillaume Chatalic's contributions to the field of neurostimulation exemplify the impact of innovative thinking in medical technology. His patents reflect a commitment to enhancing the effectiveness of medical devices, ultimately benefiting patients worldwide.